apollo

Select Address

Search Medicines
  • Login
  1. Home
  2. Pazolong Tablet

  3. Pazolong Tablet Substitute

Pazolong Tablet Substitute

Substitutes safety advice
call Doctor

Verified Ingredients and Effects

Composition:

PAZOPANIB-400MG

Uses:

Kidney cancer,  Soft tissue cancer

Medicinal Benefits:

Pazolong Tablet is a ' tyrosine kinase inhibitor (TKI)', that stops the uncontrolled growth and spread of cancerous cells. Pazolong Tablet is effective in treating thyroid, liver and kidney cancer. It acts by stopping the action of the abnormal protein that is responsible for the multiplication of cancerous cells. Whenever a new healthy cell is formed it undergoes a usual process of maturity. Cancerous cells form new cells more quickly so Pazolong Tablet targets cancerous cells and blocks the action of Tyrosine kinases enzymes (responsible for causing cancer). It also decreases the blood supply to cancer tumors to slow down the growth of the tumor.  In this way, Pazolong Tablet stops the production, spread and growth of cancerous cells in the body.

FAQs

Pazolong Tablet is safe to be taken by a diabetic person. However, take Pazolong Tablet only after asking with a doctor as they may adjust the dosing according to the condition of the patient.

Pazolong Tablet is restricted to use in pregnancy. A woman needs to have a negative pregnancy test before starting treatment with this medicine. It is better to use effective birth control methods to prevent pregnancy while taking this medicine or for at least 6 months after taking the last dose of Pazolong Tablet .

Pazolong Tablet should be stopped in cases where a person faces serious side effect that affects the quality of life. Otherwise, you need to keep taking Pazolong Tablet until your doctor asks you to stop it.

Before your doctor prescribes you Pazolong Tablet , tell them if you have heart problems, high blood pressure, bleeding issues, surgery or an electrolyte imbalance (like abnormal levels of magnesium, calcium, or potassium in the blood).

Pazolong Tablet is restricted to use in persons who are sensitive to any of its constituents or have squamous cell lung cancer or already taking carboplatin and paclitaxel.